CALIBRATE-PEDS: a phase 2/3, multicenter, single-arm study evaluating the pharmacokinetics, efficacy, and safety of encaleret in pediatric participants with autosomal dominant hypocalcemia type 1
Stefano Mora(Vita-Salute San Raffaele University), Rachel I. Gafni(National Institutes of Health), Scott Adler(CytomX Therapeutics (United States)), R. Todd Alexander(University of Alberta), Dingfeng Li(University of Science and Technology of China), Roberts Mary Scott, Raja Padidela(Manchester Academic Health Science Centre), Peter J. Tebben(Yale University)
Cited by 0
Related Papers
The landscape of aging
|Science China Life Sciences|2022|411
Biomarkers of aging
|Science China Life Sciences|2023|362
Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study
|The Lancet Diabetes & Endocrinology|2020|317
Calcium and phosphate homeostasis: Concerted interplay of new regulators
|Annals of Medicine|2008|262